PEGylated insulin (PolyMASC/Flemington)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePEGylated insulin (PolyMASC/Flemington)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin ligandInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPolyMASC Pharmaceuticals plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovaDel Pharma IncPolyMASC Pharmaceuticals plc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A